Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome
This study investigated whether sarizotan inhibits hERG potassium channels and prolongs ventricular repolarization.
Source: Journal of Molecular and Cellular Cardiology - Category: Cytology Authors: Hongwei Cheng, Chunyun Du, Yihong Zhang, Andrew F. James, Christopher E. Dempsey, Ana P. Abdala, Jules C. Hancox Source Type: research
More News: Brain | Cardiology | Cytology | Heart | Neurology | Potassium | Respiratory Medicine | Rett Syndrome | Study